Currax Pharmaceuticals LLC

TN · United States · Reporting entity ID 100000521825

Total reported 2019–2025

$19.5M

#324 of 2,960 reporting companies — 0% of all reported industry payments

$1.39M in general payments across 57,613 records, plus $18.1M in research funding across 2,708 records.

How it breaks down

General payments $1,392,348

Research funding $18,082,319

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.